Palvella CEO to Address Investors at Canaccord Conference
WAYNE, PA — Palvella Therapeutics Inc. (Nasdaq: PVLA) Chief Executive Officer Wes Kaupinen will address investors Wednesday at the Canaccord Genuity 46th Annual Growth Conference as the clinical-stage biotechnology company …
Palvella CEO to Address Investors at Canaccord Conference Read More